We are live on
!
Find out more
Boston Partners Portfolio holdings
AUM
$113B
1-Year Est. Return
38.87%
This Fund
S&P 500
This Quarter
Est. Return
+6.32%
1 Year Est. Return
+38.87%
3 Year Est. Return
+108.29%
5 Year Est. Return
+142.95%
10 Year Est. Return
+500.61%
AUM
$78.4B
AUM Growth
+$3.85B
(+5.2%)
Cap. Flow
-$180M
Cap. Flow
% of AUM
-0.23%
Top 10 Holdings %
Top 10 Hldgs %
13.07%
Holding
685
New
40
Increased
229
Reduced
367
Closed
39
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Polaris
PII
|
+$376M |
| 2 |
Wells Fargo
WFC
|
+$376M |
| 3 |
Qualcomm
QCOM
|
+$364M |
| 4 |
Centene
CNC
|
+$322M |
| 5 |
Gen Digital
GEN
|
+$302M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Medtronic
MDT
|
+$399M |
| 2 |
Steel Dynamics
STLD
|
+$340M |
| 3 |
Bank of America
BAC
|
+$269M |
| 4 |
T-Mobile US
TMUS
|
+$255M |
| 5 |
MasTec
MTZ
|
+$204M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 21.27% |
| 2 | Industrials | 14.86% |
| 3 | Healthcare | 14.33% |
| 4 | Technology | 13.97% |
| 5 | Consumer Discretionary | 12.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Howmet Aerospace
HWM
$107B
| $660M | 0.84% |
19,149,921
+175,964
| +0.9% | +$5.87M |
|
|
PXD
27
DELISTED
Pioneer Natural Resource Co.
PXD
| $636M | 0.81% |
3,912,818
-143,716
| -4% | -$22.6M |
|
28
Applied Materials
AMAT
$383B
| $633M | 0.81% |
4,451,068
-139,713
| -3% | -$18.7M |
|
29
Mohawk Industries
MHK
$8.79B
| $615M | 0.78% |
3,196,824
+18,135
| +0.6% | +$3.69M |
|
30
FMC
FMC
$1.33B
| $612M | 0.78% |
5,658,249
+461,236
| +9% | +$53.4M |
|
31
Huntington Bancshares
HBAN
$34.1B
| $609M | 0.78% |
42,668,763
-7,717,417
| -15% | -$118M |
|
32
Coca-Cola Europacific Partners
CCEP
$47.4B
| $608M | 0.77% |
10,242,640
-117,085
| -1% | -$6.83M |
|
33
Everest Group
EG
$14.5B
| $600M | 0.77% |
2,380,676
-82,003
| -3% | -$21.3M |
|
34
LKQ Corp
LKQ
$6.42B
| $595M | 0.76% |
12,085,496
+216,011
| +2% | +$10.3M |
|
|
SCHW
35
Charles Schwab
SCHW
$187B
| $595M | 0.76% |
8,170,696
+1,225,474
| +18% | +$86.7M |
|
36
Harley-Davidson
HOG
$2.9B
| $586M | 0.75% |
12,781,213
-72,635
| -0.6% | -$3.37M |
|
37
Micron Technology
MU
$1.06T
| $577M | 0.74% |
6,792,896
+508,328
| +8% | +$42.9M |
|
38
CenterPoint Energy
CNP
$25.9B
| $576M | 0.73% |
23,468,422
+68,148
| +0.3% | +$1.67M |
|
39
Novartis
NVS
$294B
| $575M | 0.73% |
6,299,760
+439,189
| +7% | +$39.1M |
|
40
Chubb
CB
$131B
| $556M | 0.71% |
3,495,773
-39,653
| -1% | -$6.57M |
|
41
Ameriprise Financial
AMP
$49.1B
| $542M | 0.69% |
2,178,318
+41,446
| +2% | +$10.4M |
|
42
American International
AIG
$40.1B
| $541M | 0.69% |
11,377,343
-1,188,465
| -9% | -$58.8M |
|
43
Cencora
COR
$61.3B
| $539M | 0.69% |
4,706,246
-221,335
| -4% | -$26.1M |
|
44
Pfizer
PFE
$160B
| $524M | 0.67% |
13,384,099
-39,170
| -0.3% | -$1.52M |
|
|
45
Wells Fargo
WFC
$257B
| $508M | 0.65% |
11,213,295
+8,420,303
| +301% | +$376M |
|
46
AbbVie
ABBV
$456B
| $504M | 0.64% |
4,470,803
+1,168,684
| +35% | +$132M |
|
47
Deere & Co
DE
$168B
| $499M | 0.64% |
1,414,482
-180,249
| -11% | -$65.8M |
|
48
Meta Platforms (Facebook)
META
$1.45T
| $496M | 0.63% |
1,425,314
+347,552
| +32% | +$111M |
|
49
General Dynamics
GD
$103B
| $493M | 0.63% |
2,618,286
-23,549
| -0.9% | -$4.44M |
|
50
Oracle
ORCL
$438B
| $489M | 0.62% |
6,279,634
-872,671
| -12% | -$68.3M |
|
Similar funds
Boston Partners's Q2 2021 Portfolio in Review
As of Q2 2021, Boston Partners held 685 positions worth $78.4B, up 5.2% from $74.6B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Boston Partners's Q2 2021 filing shows 40 new, 229 increased, 367 reduced and 39 closed positions. Its largest new stake was Polaris: 2,775,896 shares worth $380M. The largest sale was Medtronic, an estimated $399M.
By sector, the portfolio is most concentrated in Financials at 21% of assets, down from 22% a quarter earlier, followed by Industrials and Healthcare.
- Boston Partners's largest Q2 2021 buy was Polaris: 2,775,896 shares worth $380M.
- Boston Partners added most to Wells Fargo in Q2 2021, an estimated $376M increase.
- Boston Partners's biggest Q2 2021 reduction was Medtronic, cutting an estimated $399M.
- Boston Partners fully exited MasTec in Q2 2021, selling an estimated $204M.
- Boston Partners's ten largest holdings make up 13% of its $78.4B portfolio in Q2 2021.
- Boston Partners opened 40 new positions and closed 39 in Q2 2021.
- Boston Partners's portfolio value rose 5.2% quarter-over-quarter to $78.4B.
Based on Boston Partners's 13F filing for Q2 2021, filed 12 Aug 2021.